Adaptive Biotechnologies ... (ADPT)
7.01
0.94 (15.49%)
At close: Jan 15, 2025, 1:40 PM
Ratios (Annual)
Discover comprehensive ratio statement breakdowns that reveal insights into revenue, expenses, and beyond.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 |
| PE Ratio | -3.14 | -7.64 | -19.15 | -55.56 | -35.18 | -91.48 | -99.2 |
| PS Ratio | 4.15 | 5.88 | 25.52 | 78.86 | 24.33 | 76.33 | 110.51 |
| PB Ratio | 2.29 | 2.35 | 6.52 | 10.44 | 3.62 | -16.46 | -18.92 |
| P/FCF Ratio | -4.24 | -5.44 | -15.48 | -46.05 | 10.66 | -110.14 | -113.72 |
| P/OCF Ratio | -4.53 | -5.92 | -20.43 | -51.84 | 10.07 | -131.71 | -121.89 |
| OCF/S Ratio | -0.92 | -0.99 | -1.25 | -1.52 | 2.41 | -0.58 | -0.91 |
| Debt / Equity Ratio | 0.74 | 0.23 | 0.19 | 0.15 | 0.06 | -2.17 | -2.5 |
| Quick Ratio | 4.50 | 4.99 | 3.37 | 6.78 | 7.71 | 7.58 | 9.54 |
| Current Ratio | 4.66 | 5.12 | 3.54 | 6.91 | 7.82 | 7.93 | 9.77 |
| Asset Turnover | 0.26 | 0.22 | 0.17 | 0.09 | 0.09 | 0.17 | 0.11 |
| Interest Coverage | -16.45 | -47.24 | n/a | n/a | n/a | n/a | n/a |
| Return on Equity (ROE) | -0.73 | -0.31 | -0.34 | -0.19 | -0.1 | 0.18 | 0.19 |
| Return on Assets (ROA) | -0.34 | -0.17 | -0.22 | -0.13 | -0.06 | -0.14 | -0.12 |
| Return on Capital (ROIC) | -0.4 | -0.27 | -0.26 | -0.15 | -0.09 | -0.16 | -0.13 |
| Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Gross Profit Margin | 55.63% | 68.75% | 68.06% | 77.10% | 73.82% | 64.67% | 59.22% |
| Net Profit Margin | -132.29% | -76.88% | -133.22% | -141.93% | -69.14% | -83.44% | -111.4% |
| Pretax Profit Margin | -132.32% | -108.13% | -134.31% | -148.63% | -80.65% | -83.44% | -111.4% |
| Operating Profit Margin | -133.33% | -108.03% | -135.39% | -155.33% | -92.15% | -89.39% | -115.68% |
| FCF Margin | -98.09% | -108.09% | -164.87% | -171.26% | 228.28% | -69.3% | -97.18% |
| EBITDA Margin | -111.16% | -90.65% | -125.27% | -146.72% | -82.99% | -78.61% | -98.42% |